Kiadis Pharma

Kiadis Pharma manufactures an individual cell-based medicinal product for end-stage leukemia patients at contract manufacturers in Europe and North America. To generate this product, within this pharmaceutical process cells need to be illuminated at a tightly controlled dose (J/cm2) within a set time. This process is executed with the Theralux device.